ArrowMark Colorado Holdings’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

ArrowMark Colorado Holdings’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-410,797	Closed	-$19.1M	–	334
2023 Q2	$19.1M	Sell	410,797 -1,412	-0.3%	-$48.8K	0.21%	99
2023 Q1	$11.8M	Sell	412,209 -2,622	-0.6%	-$77.7K	0.13%	127
2022 Q4	$12.9M	Sell	414,831 -216,302	-34%	-$7.05M	0.15%	117
2022 Q3	$12.8M	Buy	631,133 +11,700	+2%	+$213K	0.16%	122
2022 Q2	$9.61M	Buy	619,433 +170,599	+38%	+$2.93M	0.11%	167
2022 Q1	$8.59M	Buy	448,834 +23,737	+6%	+$424K	0.08%	206
2021 Q4	$10.8M	Buy	425,097 +14,664	+4%	+$430K	0.09%	188
2021 Q3	$13.4M	Buy	+410,433	New	+$14M	0.11%	163

ArrowMark Colorado Holdings's DICE Position: Q3 2023 in Review

ArrowMark Colorado Holdings sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 410,797 shares — an estimated $19.1M sold.

ArrowMark Colorado Holdings first reported a position in DICE in Q3 2021 and held it in 8 quarters. The position peaked at $19.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

ArrowMark Colorado Holdings reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
ArrowMark Colorado Holdings sold 410,797 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $19.1M.
ArrowMark Colorado Holdings first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
ArrowMark Colorado Holdings's DICE Therapeutics, Inc. Common Stock position peaked at $19.1M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.